The Study of Pain in Rats and Mice
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Failure to Launch? the Influence of Limb Autotomy on the Escape Behavior of a Semiaquatic Grasshopper Paroxya Atlantica
Behavioral Ecology doi:10.1093/beheco/arr045 Advance Access publication 4 May 2011 Original Article Failure to launch? The influence of limb autotomy on the escape behavior of a semiaquatic grasshopper Paroxya atlantica (Acrididae) Philip W. Batemana,b,c and Patricia A. Flemingb aDepartment of Zoology and Entomology, University of Pretoria, Pretoria 0002, South Africa, bSchool of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, WA 6150, Australia, and cArchbold Biological Station, Lake Placid, PO Box 2057, Lake Placid, FL 33862, USA Downloaded from Autotomy is an extreme escape tactic where an animal sheds an appendage to escape predation. Many species alter their behavior postautotomy to compensate for this loss. We examined the escape behavior in the field of a semiaquatic grasshopper (Paroxya atlantica) that could escape either by flight and landing in vegetation or flight and landing in water and swimming to safety. We predicted that animals missing a hind limb would be more reactive (i.e., have longer flight initiation distances; FID) and would beheco.oxfordjournals.org prefer to escape to vegetation rather than to water as loss of a limb is likely to reduce swimming ability. However, our predictions were not supported. FID in autotomized animals was not different from that in intact animals. Furthermore, although autotom- ized grasshoppers paused more often and swam slower than intact individuals, autotomized grasshoppers more often escaped to water, reaching it via shorter flights that were lateral to the approach of the observer (intact grasshoppers more often flew directly away from the observer). We also noted differences in behavior before disturbance: Autotomised animals perched lower on emergent vegetation than did intact ones, presumably in readiness for escape via water, and also showed a greater likelihood to at Murdoch University on June 19, 2011 hide (squirreling) from the approaching observer prior to launch into flight. -
Mantodea (Insecta), with a Review of Aspects of Functional Morphology and Biology
aua o ew eaa Ramsay, G. W. 1990: Mantodea (Insecta), with a review of aspects of functional morphology and biology. Fauna of New Zealand 19, 96 pp. Editorial Advisory Group (aoimes mae o a oaioa asis MEMBERS AT DSIR PLANT PROTECTION Mou Ae eseac Cee iae ag Aucka ew eaa Ex officio ieco — M ogwo eae Sysemaics Gou — M S ugae Co-opted from within Systematics Group Dr B. A ooway Κ Cosy UIESIIES EESEAIE R. M. Emeso Eomoogy eame ico Uiesiy Caeuy ew eaa MUSEUMS EESEAIE M R. L. ama aua isoy Ui aioa Museum o iae ag Weigo ew eaa OESEAS REPRESENTATIVE J. F. awece CSIO iisio o Eomoogy GO o 1700, Caea Ciy AC 2601, Ausaia Series Editor M C ua Sysemaics Gou SI a oecio Mou Ae eseac Cee iae ag Aucka ew eaa aua o ew eaa Number 19 Maoea (Iseca wi a eiew o asecs o ucioa mooogy a ioogy G W Ramsay SI a oecio M Ae eseac Cee iae ag Aucka ew eaa emoa us wig mooogy eosigma cooaio siuaio acousic sesiiiy eece eaiou egeeaio eaio aasiism aoogy a ie Caaoguig-i-uicaio ciaio AMSAY GW Maoea (Iseca – Weigo SI uisig 199 (aua o ew eaa ISS 111-533 ; o 19 IS -77-51-1 I ie II Seies UC 59575(931 Date of publication: see cover of subsequent numbers Suggese om o ciaio amsay GW 199 Maoea (Iseca wi a eiew o asecs o ucioa mooogy a ioogy Fauna of New Zealand [no.] 19. —— Fauna o New Zealand is eae o uicaio y e Seies Eio usig comue- ase e ocessig ayou a ase ie ecoogy e Eioia Aisoy Gou a e Seies Eio ackowege e oowig co-oeaio SI UISIG awco – sueisio o oucio a isiuio M C Maews – assisace wi oucio a makeig Ms A Wig – assisace wi uiciy a isiuio MOU AE ESEAC CEE SI Miss M oy -
Development of Macromolecular Prodrugs for the Treatment of Chronic Inflammatory Pain
University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Fall 12-14-2018 Development of Macromolecular Prodrugs for the Treatment of Chronic Inflammatory Pain Laura Weber University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Pharmacy and Pharmaceutical Sciences Commons Recommended Citation Weber, Laura, "Development of Macromolecular Prodrugs for the Treatment of Chronic Inflammatory Pain" (2018). Theses & Dissertations. 323. https://digitalcommons.unmc.edu/etd/323 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. DEVELOPMENT OF MACROMOLECULAR PRODRUGS FOR THE TREATMENT OF CHRONIC INFLAMMATORY PAIN By Laura Weber A DISSERTATION Presented to the Faculty of The Graduate College of the University of NeBraska In Partial Fulfillment of the Requirements For the Degree of Doctor of Philosophy Department of Pharmaceutical Sciences Under the Supervision of Professor Dong Wang University of NeBraska Medical Center Omaha, NeBraska DecemBer 2018 TABLE OF CONTENTS ACKNOWLEDGEMENTS .............................................................................................. I ABSTRACT ................................................................................................................. IV LIST OF -
Tail Autotomy Plays No Important Role in Influencing Locomotor Performance and Antipredator Behavior in a Cursorial Gecko
ethology international journal of behavioural biology Ethology Tail Autotomy Plays No Important Role in Influencing Locomotor Performance and Anti-Predator Behavior in a Cursorial Gecko Hong-Liang Lu* , Guo-Hua Ding , Ping Ding* & Xiang Ji * Key Laboratory of Conservation Biology for Endangered Wildlife of the Ministry of Education, College of Life Sciences, Zhejiang University, Hangz- hou 310058, Zhejiang, China Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, Jiangsu, China Correspondence Abstract Xiang Ji, Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life We used the frog-eyed sand gecko (Teratoscincus scincus) as a model sys- Sciences, Nanjing Normal University, Nanjing tem to evaluate the locomotor costs of tail loss, and to examine whether 210046, Jiangsu, China. tailless geckos use alternative anti-predator behavior to compensate for E-mail: [email protected], xiangji150@ the costs of tail loss. Of the 16 field-captured geckos, eight were used as hotmail.com experimental animals and the remaining ones as controls. Locomotor performance, activity level and anti-predator behavior were measured Received: January 21, 2010 Initial acceptance: February 22, 2010 for experimental geckos before and after the tail-removing treatment. Final acceptance: March 15, 2010 Control geckos never undergoing the tail-removing manipulation were (J. Kotiaho) measured to serve as controls for the measurements taken at the same time for experimental geckos. Experimental geckos did not differ from doi: 10.1111/j.1439-0310.2010.01780.x controls in activity level before they underwent the tail-removing manipulation, but became less active thereafter. -
Modulation of the Mu and Kappa Opioid Axis for Treatment of Chronic Pruritus
Modulation of the Mu and Kappa Opioid Axis for the Treatment of Chronic Pruritus Sarina Elmariah, MD, PhD1, Sarah Chisolm, MD2, Thomas Sciascia, MD3, Shawn G. Kwatra, MD4 1Massachusetts General Hospital, Boston, MA, USA; 2Emory University Department of Dermatology, Atlanta, GA, USA; VA VISN 7, USA; 3Trevi Therapeutics, New Haven, CT, USA; 4Johns Hopkins University School of Medicine, Baltimore, MD, USA Introduction Results Conclusions • Conditions such as uremic pruritus (UP) and prurigo nodularis • In the United States, opioid receptor–targeting agents have been used off-label to Figure 4. Change in VAS Scores From Baseline (Preobservation Period) to Last 7 – In a patient subgroup with severe UP (n=179), sleep disruption attributed to • These data suggest that agents that modulate underlying are characterized by chronic pruritus, which negatively impacts treat chronic itch19 Days of Treatment With KOR Agonist Nalfurafine vs Placebo for Uremic Pruritus21 itching improved significantly vs placebo (P=0.006) neurologic components of pruritus through µ-antagonism quality of life (QoL), sleep, and mood1-7 and/or κ-agonism are effective and safe options for the • Several agents that target MORs and KORs are being used off-label or are in clinical alfurafine 2.5 µg alfurafine 5 µg Placeo – The most common reason for discontinuing treatment was gastrointestinal side n112 n114 n111 treatment of chronic pruritus • Opioid receptors and their endogenous ligands are involved in development for the treatment of chronic itch associated with various disease states 0 effects (eg, nausea, vomiting) during titration the regulation of itch, with activation of mu (µ) opioid receptors (Figure 2) These agents have low abuse potential and generally appear well Figure 5. -
Evaluation of Antinociceptive Effects of Chitosan-Coated Liposomes Entrapping the Selective Kappa Opioid Receptor Agonist U50,488 in Mice
medicina Article Evaluation of Antinociceptive Effects of Chitosan-Coated Liposomes Entrapping the Selective Kappa Opioid Receptor Agonist U50,488 in Mice Liliana Mititelu Tartau 1, Maria Bogdan 2,* , Beatrice Rozalina Buca 1, Ana Maria Pauna 1, Cosmin Gabriel Tartau 1, Lorena Anda Dijmarescu 3 and Eliza Gratiela Popa 4 1 Department of Pharmacology, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania; liliana.tartau@umfiasi.ro (L.M.T.); beatrice-rozalina.buca@umfiasi.ro (B.R.B.); ana-maria-raluca-d-pauna@umfiasi.ro (A.M.P.); [email protected]fiasi.ro (C.G.T.) 2 Department of Pharmacology, Faculty of Pharmacy, University of Medicine and Pharmacy, 200349 Craiova, Romania 3 Department of Obstetrics-Gynecology, Faculty of Medicine, University of Medicine and Pharmacy, 200349 Craiova, Romania; [email protected] 4 Department of Pharmaceutical Technology, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania; eliza.popa@umfiasi.ro * Correspondence: [email protected] Abstract: Background and Objectives: The selective kappa opioid receptor agonist U50,488 was reported to have analgesic, cough suppressant, diuretic and other beneficial properties. The aim of our study was to analyze the effects of some original chitosan-coated liposomes entrapping U50,488 in somatic and visceral nociceptive sensitivity in mice. Materials and Methods: The influence on the somatic pain was assessed using a tail flick test by counting the tail reactivity to thermal noxious stimulation. Citation: Mititelu Tartau, L.; Bogdan, The nociceptive visceral estimation was performed using the writhing test in order to evaluate the M.; Buca, B.R.; Pauna, A.M.; Tartau, behavioral manifestations occurring as a reaction to the chemical noxious peritoneal irritation with C.G.; Dijmarescu, L.A.; Popa, E.G. -
Characterization of Arm Autotomy in the Octopus, Abdopus Aculeatus (D’Orbigny, 1834)
Characterization of Arm Autotomy in the Octopus, Abdopus aculeatus (d’Orbigny, 1834) By Jean Sagman Alupay A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Integrative Biology in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Roy L. Caldwell, Chair Professor David Lindberg Professor Damian Elias Fall 2013 ABSTRACT Characterization of Arm Autotomy in the Octopus, Abdopus aculeatus (d’Orbigny, 1834) By Jean Sagman Alupay Doctor of Philosophy in Integrative Biology University of California, Berkeley Professor Roy L. Caldwell, Chair Autotomy is the shedding of a body part as a means of secondary defense against a predator that has already made contact with the organism. This defense mechanism has been widely studied in a few model taxa, specifically lizards, a few groups of arthropods, and some echinoderms. All of these model organisms have a hard endo- or exo-skeleton surrounding the autotomized body part. There are several animals that are capable of autotomizing a limb but do not exhibit the same biological trends that these model organisms have in common. As a result, the mechanisms that underlie autotomy in the hard-bodied animals may not apply for soft bodied organisms. A behavioral ecology approach was used to study arm autotomy in the octopus, Abdopus aculeatus. Investigations concentrated on understanding the mechanistic underpinnings and adaptive value of autotomy in this soft-bodied animal. A. aculeatus was observed in the field on Mactan Island, Philippines in the dry and wet seasons, and compared with populations previously studied in Indonesia. -
Chronic Kidney Disease-Associated Pruritus
toxins Review Chronic Kidney Disease-Associated Pruritus Puneet Agarwal 1 , Vinita Garg 2, Priyanka Karagaiah 3, Jacek C. Szepietowski 4 , Stephan Grabbe 5 and Mohamad Goldust 5,* 1 Department of Dermatology, SMS Medical College and Hospital, Jaipur 302004, Rajasthan, India; [email protected] 2 Consultant Nephrologist, MetroMas Hospital, Jaipur 302020, Rajasthan, India; [email protected] 3 Department of Dermatology, Bangalore Medical College and Research Institute, Bangalore 560002, Karnataka, India; [email protected] 4 Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-367 Wroclaw, Poland; [email protected] 5 Department of Dermatology, University Medical Center Mainz, Langenbeckstraße 1, 55131 Mainz, Germany; [email protected] * Correspondence: [email protected] Abstract: Pruritus is a distressing condition associated with end-stage renal disease (ESRD), advanced chronic kidney disease (CKD), as well as maintenance dialysis and adversely affects the quality of life (QOL) of these patients. It has been reported to range from 20% to as high as 90%. The mechanism of CKD-associated pruritus (CKD-aP) has not been clearly identified, and many theories have been proposed to explain it. Many risk factors have been found to be associated with CKD-aP. The pruritus in CKD presents with diverse clinical features, and there are no set features to diagnose it.The patients with CKD-aP are mainly treated by nephrologists, primary care doctors, and dermatologists. Many treatments have been tried but nothing has been effective. The search of literature included peer- reviewed articles, including clinical trials and scientific reviews. Literature was identified through March 2021, and references of respective articles and only articles published in the English language were included. -
Full-Text (PDF)
Original Article J Babol Univ Med Sci Vol 18, Issu 12; Dec 2016. P:64-70 The Effect of Copper Chloride (CuCl2) on Pain and Inflammatory Paw Edema in Rats H. Nikbakhty (MSc)1, M. Fereidoni (PhD)1, A. Asadollahi (PhD)1 1. Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, I.R.Iran J Babol Univ Med Sci; 18(12); Dec 2016; PP: 64-70 Received: Jul 12th 2016, Revised: Jul 27th 2016, Accepted: Sep 27th 2016. ABSTRACT BACKGROUND AND OBJECTIVE: As a crucial micronutrient, copper ion is engaged in various biochemical pathways and affects central nervous system, pain, and inflammation. Considering the significance of pain in physical and mental condition of patients, the present study aims to find new ways to reduce pain by investigating the effect of copper chloride on thermal and chemical pain and inflammatory edema through central and peripheral administrations. METHODS: In this empirical study, 77 male Wister rats (200–250g) were divided into 11 groups (n=7) including control group (with no treatment), sham 1 (saline, i.p) receiving 5, 10, 20 and 100 mg/kg CuCl2 intraperitoneally (i.p), sham 2 (saline, intrathecal (i.t)) receiving 0.002mg/10µl and 0.02mg/10µl CuCl2 intrathecally (i.t), sham 3 group receiving saline plus naloxone intraperitoneally (i.p) and the group receiving 10 mg/kg CuCl2 plus 2 mg/kg naloxone intraperitoneally (i.p). Thermal and chemical pain and the volume of inflammatory edema were assessed using tail flick, formalin and plethysmometery tests, respectively. Elevated plus maze and rotarod tests were used to examine the side effects of CuCl2. -
Systemic Kappa Opioid Receptor Agonists in the Treatment of Chronic Pruritus: a Literature Review
Included in the theme issue: ATOPIC DERMATITIS, URTICARIA AND ITCH Acta Derm Venereol 2012; 92: 555–560 Acta Derm Venereol 2012; 92: 449–581 REVIEW ARTICLE Systemic Kappa Opioid Receptor Agonists in the Treatment of Chronic Pruritus: A Literature Review Ngoc Quan PHAN1, Tobias LOTTS1, Attila Antal2, Jeffrey D. BERNHARD3 and Sonja STÄNDER1 1Competence Center Chronic Pruritus, Department of Dermatology, University Hospital Münster, Münster, 2Department of Dermatology and Allergology Ludwig-Maximilians-University, München, Germany, and 3Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachu- setts, USA Chronic pruritus is frequently refractory to currently studies antipruritic effects in antihistamine-resistant and available treatments. Studies suggest that pruritus may antihistamine-sensitive pruritus in animals and humans arise from an imbalance of the mu- and kappa-opioid re- (3, 4). Given that an imbalance of the endogenous opioid ceptor system activity in either the skin or the central system has been considered as a pathomechanism in nervous system. Stimulation of kappa-opioid receptors uraemic pruritus, antipruritic effects of KOR agonists by their agonists inhibits pruritus in both animals and have been investigated in randomized controlled trials humans. The antipruritic effect of kappa-opioid recep- (RCT) in this indication (5–8). The major advantage of tors agonists can currently be assumed to be related to the KOR agonists over MOR antagonists seems to be their binding to kappa-opioid receptors on keratinocy- the fewer rates of up-to-date reported adverse events. tes and cutaneous and/or central itch neurones. To date, MOR antagonists show a high rate of troublesome side- several case reports and 2 controlled trials have de- effects (1), hampering their application mainly in elderly monstrated a beneficial effect of systemic kappa-opioid patients. -
Science, Sentience, and Animal Welfare
WellBeing International WBI Studies Repository 1-2013 Science, Sentience, and Animal Welfare Robert C. Jones California State University, Chico, [email protected] Follow this and additional works at: https://www.wellbeingintlstudiesrepository.org/ethawel Part of the Animal Studies Commons, Ethics and Political Philosophy Commons, and the Nature and Society Relations Commons Recommended Citation Jones, R. C. (2013). Science, sentience, and animal welfare. Biology and Philosophy, 1-30. This material is brought to you for free and open access by WellBeing International. It has been accepted for inclusion by an authorized administrator of the WBI Studies Repository. For more information, please contact [email protected]. Science, Sentience, and Animal Welfare Robert C. Jones California State University, Chico KEYWORDS animal, welfare, ethics, pain, sentience, cognition, agriculture, speciesism, biomedical research ABSTRACT I sketch briefly some of the more influential theories concerned with the moral status of nonhuman animals, highlighting their biological/physiological aspects. I then survey the most prominent empirical research on the physiological and cognitive capacities of nonhuman animals, focusing primarily on sentience, but looking also at a few other morally relevant capacities such as self-awareness, memory, and mindreading. Lastly, I discuss two examples of current animal welfare policy, namely, animals used in industrialized food production and in scientific research. I argue that even the most progressive current welfare policies lag behind, are ignorant of, or arbitrarily disregard the science on sentience and cognition. Introduction The contemporary connection between research on animal1 cognition and the moral status of animals goes back almost 40 years to the publication of two influential books: Donald Griffin’s The Question of Animal Awareness: Evolutionary Continuity of Mental Experience (1976) and Peter Singer’s groundbreaking Animal Liberation (1975). -
(12) Patent Application Publication (10) Pub. No.: US 2011/0245287 A1 Holaday Et Al
US 20110245287A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0245287 A1 Holaday et al. (43) Pub. Date: Oct. 6, 2011 (54) HYBRD OPOD COMPOUNDS AND Publication Classification COMPOSITIONS (51) Int. Cl. A6II 3/4748 (2006.01) C07D 489/02 (2006.01) (76) Inventors: John W. Holaday, Bethesda, MD A6IP 25/04 (2006.01) (US); Philip Magistro, Randolph, (52) U.S. Cl. ........................................... 514/282:546/45 NJ (US) (57) ABSTRACT Disclosed are hybrid opioid compounds, mixed opioid salts, (21) Appl. No.: 13/024,298 compositions comprising the hybrid opioid compounds and mixed opioid salts, and methods of use thereof. More particu larly, in one aspect the hybrid opioid compound includes at (22) Filed: Feb. 9, 2011 least two opioid compounds that are covalently bonded to a linker moiety. In another aspect, the hybrid opioid compound relates to mixed opioid salts comprising at least two different Related U.S. Application Data opioid compounds or an opioid compound and a different active agent. Also disclosed are pharmaceutical composi (60) Provisional application No. 61/302,657, filed on Feb. tions, as well as to methods of treating pain in humans using 9, 2010. the hybrid compounds and mixed opioid salts. Patent Application Publication Oct. 6, 2011 Sheet 1 of 3 US 2011/0245287 A1 Oral antinociception of morphine, oxycodone and prodrug combinations in CD1 mice s Tigkg -- Morphine (2.80 mg/kg (1.95 - 4.02, 30' peak time -- (Oxycodone (1.93 mg/kg (1.33 - 2,65)) 30 peak time -- Oxy. Mor (1:1) (4.84 mg/kg (3.60 - 8.50) 60 peak tire --MLN 2-3 peak, effect at a hors 24% with closes at 2.5 art to rigg - D - MLN 2-45 (6.60 mg/kg (5.12 - 8.51)} 60 peak time Figure 1.